ESCRS Preview

Article

OTEurope reveals highlights from each day of the ESCRS Congress with the help of three EAB members.

XXXI Congress of the ESCRS

5–9 October 2013, RAI, Amsterdam, The Netherlands

This year's major European event is nearing and the excitement of what will be revealed at the show is peaking once more. The XXXI event will be taking place in the canal ensued Amsterdam in The Netherlands and yet again expectant attendees and exhibitors will have much to look forward to in the packed out programme.

We hope you will find this a useful resource for your event and do also check out the ESCRS Showcase section, directly following this preview feature, for a brief overview of some exciting products that will be on the exhibition floor between 5–8 October.

Friday 4 October

ESCRS Glaucoma Day - 8.30 am–5.30 pm

Once again, the ESCRS will be immediately preceded by the ever popular ESCRS Glaucoma Day. Organized by the European Glaucoma Society (EGS), this year's programme will feature five sessions, covering four main topic areas - Glaucoma Burden, A Challenge To The IOP Concept, Medical Treatment and Surgery in Glaucoma. As with previous year's presentations will be made by key opinion leaders in the field of glaucoma and it is certain the day will not disappoint those attending.

This year, OTEurope's highlights include: Dr Augusto Azuara Blanco's discussion on 'The burden of glaucoma on patients and society: direct and indirect costs', Dr Luciano Quaranta's talk titled, 'How many IOP measurements do we need to make clinical decisions?', Dr Jean-Philippe Nordmann's presentation on 'Quality of generic drugs: equivalent to originals?', Dr Tarek Shaarawy's talk highlighting 'Minimally invasive glaucoma devices: what is the evidence?', and Dr John Thygesen's discussion on "The prevalence of angle closure in Europe'.

The meeting has been awarded 6 CME credits and potential attendees will need to register separately for this meeting. Registration will cost €150 plus VAT.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.